Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain.

Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E.

J Pharmacol Exp Ther. 2007 Jun;321(3):1208-25. Epub 2007 Feb 26.

2.

Serotonin and noradrenaline reuptake inhibitors in animal models of pain.

Mochizucki D.

Hum Psychopharmacol. 2004 Oct;19 Suppl 1:S15-9. Review.

PMID:
15378668
3.

Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.

McGaraughty S, Jarvis MF.

Drug News Perspect. 2005 Oct;18(8):501-7. Review.

PMID:
16391720
4.

Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics.

Varney MA, Gereau RW 4th.

Curr Drug Targets CNS Neurol Disord. 2002 Jun;1(3):283-96. Review.

PMID:
12769620
5.

Spinal mechanisms of NPY analgesia.

Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK.

Peptides. 2007 Feb;28(2):464-74. Epub 2006 Dec 27. Review.

PMID:
17194506
6.

Pharmacology of opioid and nonopioid analgesics in chronic pain states.

Martin TJ, Eisenach JC.

J Pharmacol Exp Ther. 2001 Dec;299(3):811-7. Review.

7.

Potential use of melatonergic drugs in analgesia: mechanisms of action.

Srinivasan V, Pandi-Perumal SR, Spence DW, Moscovitch A, Trakht I, Brown GM, Cardinali DP.

Brain Res Bull. 2010 Mar 16;81(4-5):362-71. doi: 10.1016/j.brainresbull.2009.12.001. Epub 2010 Jan 19. Review.

PMID:
20005925
8.

Distinct neurochemical features of acute and persistent pain.

Basbaum AI.

Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7739-43. Review.

9.

Visceral pain in humans: lessons from animals.

Buffington CA.

Curr Pain Headache Rep. 2001 Feb;5(1):44-51. Review.

PMID:
11252137
10.

Clinical application of adenosine and ATP for pain control.

Hayashida M, Fukuda K, Fukunaga A.

J Anesth. 2005;19(3):225-35. Review.

PMID:
16032451
11.

Dopamine: biphasic dose responses.

Calabrese EJ.

Crit Rev Toxicol. 2001 Jul;31(4-5):563-83. Review.

PMID:
11504182
12.

Serotonin in pain and analgesia: actions in the periphery.

Sommer C.

Mol Neurobiol. 2004 Oct;30(2):117-25. Review.

PMID:
15475622
13.

Perspectives in the control of chronic pain by nutritional manipulation.

Seltzer S, Marcus R, Stoch R.

Pain. 1981 Oct;11(2):141-8. Review.

PMID:
6119671
14.

Human experimental pain models in drug development: translational pain research.

Arendt-Nielsen L, Curatolo M, Drewes A.

Curr Opin Investig Drugs. 2007 Jan;8(1):41-53. Review.

PMID:
17263184
15.

Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Braga PC.

Agents Actions. 1994 May;41(3-4):121-31. Review.

PMID:
7942319
16.

Mesolimbic dopaminergic mechanisms and pain control.

Wood PB.

Pain. 2006 Feb;120(3):230-4. Epub 2006 Jan 19. Review. No abstract available.

PMID:
16427195
17.
18.

Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.

Manepalli S, Surratt CK, Madura JD, Nolan TL.

AAPS J. 2012 Dec;14(4):820-31. doi: 10.1208/s12248-012-9391-0. Epub 2012 Aug 24. Review.

19.

Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.

McGaraughty S, Cowart M, Jarvis MF, Berman RF.

Curr Top Med Chem. 2005;5(1):43-58. Review.

PMID:
15638777
20.

Microdialysis in pain research.

Stiller CO, Taylor BK, Linderoth B, Gustafsson H, Warsame Afrah A, Brodin E.

Adv Drug Deliv Rev. 2003 Aug 28;55(8):1065-79. Review.

PMID:
12935945
Items per page

Supplemental Content

Write to the Help Desk